I. Burlaka

发表

Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease.

H. Brismar, A. Fogo, L. Scott, 2016, Kidney international.

Endogenous Cardiotonic Steroids Levels and their Significance in Childrenwith Chronic Kidney Disease

I. Burlaka, 2020 .

Prevention of apoptotic onset rescues from glomerular tubular disconnection and podocyte loss in proteinuric kidney disease

H. Brismar, A. Fogo, L. Scott, 2018 .

Chronic intracellular hypoxia as a clustering and stratifying factor for clinical severity grade in nephrotic syndrome in children

I. Burlaka, I. Bagdasarova, I. Mityuryayeva, 2021, Ukrainian Journal of Nephrology and Dialysis.

Association of Vitamin D deficiency, cellular hypoxia, and caspase-3 with renal disease in pediatric diabetic nephropathy

I. Burlaka, V. Maidannyk, 2016 .

Apoptosis as a mechanism of the albumin-induced kidney damage in childhood nephrotic syndrome

I. Burlaka, I. Bagdasarova, 2018, Ukrainian Journal of Nephrology and Dialysis.

Vitamin D as a Multiple Player Under the Physiological and Pathological Conditions and in Diabetic Nephropathy in Children

I. Burlaka, V. Maidannyk, 2019 .

Approach to correction of apoptotic disorders in children with early diabetic nephropathy ‎

I. Burlaka, 2022, Journal Of Advanced Pharmacy Education And Research.

Beyond Proteinuria: Apoptosis and Vitamin D3 State in Children with Diabetic Nephropathy

I. Burlaka, 2016 .

Clinical and Apoptotic Factors Defining and Predicting Steroid Resistance in Nephrotic Syndrome in Children

I. Burlaka, I. Bagdasarova, I. Mityuryayeva, 2021, Global pediatric health.

Calcium oscillations triggered by cardiotonic steroids

H. Brismar, A. Aperia, I. Burlaka, 2013, The FEBS journal.

Nephroprotective effect of the cardiotonic steroid ouabain

I. Burlaka, 2014 .

Usage and Attitudes Towards Natural Remedies and Homeopathy in General Pediatrics

A. Pettenazzo, B. Kamenov, I. Burlaka, 2016, Global pediatric health.

To the Question of Vitamin D Network in Type 1 Diabetes and Diabetic Nephropathy in Children Nursed in Ukrainian Endocrinology Unit

I. Burlaka, I. Mityuryayeva, 2022, SAGE open nursing.

Clinical, Laboratory, Instrumental, Anamnestic Characteristics in Children With Type I Diabetes Mellitus and Early Stage of Diabetic Nephropathy

I. Burlaka, I. Mityuryayeva, T. Shevchenko, 2021, Global pediatric health.

Molecular factors predicting steroid resistance in pediatric nephrotic syndrome

I. Burlaka, I. Bagdasarova, 2021, Ukrainian Journal of Nephrology and Dialysis.

Albumin-Induced Primary Disorders in Nephrotic Syndrome : Experimental and Clinical Data

I. Burlaka, 2017 .

Management of Hypoxia-induced Disorders in Nephrotic Children

I. Burlaka, Maidannyk, 2015 .

Violations in apoptosis control system in children with nephrotic syndrome

I. Burlaka, Maidannyk Vg, 2014 .

Vitamin D in Diabetic Nephropathy: Today, Tomorrow, Always

I. Burlaka, 2020 .

Ouabain protects against Shiga toxin-triggered apoptosis by reversing the imbalance between Bax and Bcl-xL.

H. Brismar, A. Aperia, X. Liu, 2013, Journal of the American Society of Nephrology : JASN.

Early functional and metabolic disorders in children with type 1 diabetes mellitus and diabetic nephropathy

I. Burlaka, V. Maidannyk, 2021, Pediatric endocrinology, diabetes, and metabolism.

DIABETIC NEPHROPATHY: NOVELTY ABOUT THE DIABETIC NEPHROPATHY TREATMENT IN CHILDREN.

I. Burlaka, I. Mityuryayeva, T. Shevchenko, 2023, Wiadomosci lekarskie.

Ouabain protects against Shiga toxin-triggered apoptosis by reversing the imbalance between Bax and Bcl-xL.

H. Brismar, A. Aperia, X. Liu, 2013, Journal of the American Society of Nephrology : JASN.

Mechanism of Apoptosis in Development of Glomerular Damage in Nephrotic Children

I. Burlaka, 2018 .

Analysis of Apoptotic, Clinical, and Laboratory Parameters in Type 1 Diabetes and Early Diabetic Nephropathy: Clustering and Potential Groups Evaluation for Additional Therapeutic Interventions

I. Burlaka, 2022, Journal of clinical research in pediatric endocrinology.